川崎病患儿冠状动脉病变的危险因素调查

doi:10.3969/j.issn.1006-5253.2020.04.006

Abstract
Figure/Table
References (0)
Related Citation (15)

Download: PDF (1200 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To explore the incidence rate and risk factors of children Kawasaki disease (KD) complication with coronary artery lesion (CAL). Methods Totally 283 children with KD were retrospectively investigated, and they were divided into the CAL group and the NCAL group according to the occurrence of coronary artery disease. The incidence rate of CAL in children with KD was described, and the high risk factors of CAL in children with KD were screened by χ2 test and multiple factors logistic regression methods. Results The incidence rate of CAL in 283 children with KD was 31.10%. The risk factors of CAL in children with KD included heating time (OR=2.818), delayed diagnosis and treatment (OR=3.459), hs-CRP (OR=3.815), erythrocyte sedimentation rate (OR=4.031), cTnI (OR=5.618) and IVIG resistance (OR=4.618). Conclusion Children KD have a high incidence rate of CAL. To aim directly at these above high risk factors, we should early screen, diagnose and treat children with KD, to cut down the incidence rate of CAL, and improve the prognosis of children with KD.

Key words： Kawasaki disease child coronary artery lesion risk factor

Received: 17 December 2019

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	Zhou Lizhen
	Wang Yangyan.

Cite this article:

Zhou Lizhen,Wang Yangyan.. Investigation on risk factors of children Kawasaki disease complication with coronary artery lesion[J]. journal1, 2020, 27(4): 311-314.

URL:

http://manu58.magtech.com.cn/Jwk_zgyytj/EN/10.3969/j.issn.1006-5253.2020.04.006 OR http://manu58.magtech.com.cn/Jwk_zgyytj/EN/Y2020/V27/I4/311

［1］徐雯雅,刘桂英.川崎病合并冠状动脉损害危险因素研究进展［J］.中国医药,2016,11(2):293-297.
［2］李焰,王献民,柳颐龄,等.川崎病患儿并发冠状动脉病变的危险因素分析［J］.中国当代儿科杂志,2012,14(12):938-941.
［3］杨艳章,王莉,杨艳芳,等.川崎病患儿并发冠状动脉病变相关危险因素与治疗分析［J］.中国妇幼保健,2019,34(14):3244-3246.
［4］AYUSAWA M, SONEODE T, UEMURA S, et al. Revision of diagnostic guidelines for Kawasaki disease (the 4 revised edition) ［J］. Pediatr Int, 2005, 47(2): 232-234.
［5］胡亚美,江载芳.诸福棠实用儿科学［M］.7版.北京:人民卫生出版社,2012：701.
［6］马锦,毛晨梅.川崎病患儿冠状动脉病变相关危险因素分析［J］.江苏医药,2018,44(2):151-153.
［7］何伟玲,徐晓穗,苏晓琴.川崎病冠状动脉损害与发热持续时间的相关性及高危因素分析［J］.临床医学工程,2018,25(7):975-976.
［8］张春伟,吴慧,李燕林.川崎病并发冠状动脉损害的危险因素分析［J］.临床医学,2016,36(11):7-9.
［9］刘奇峰,胡永科,杜欣.川崎病患儿并发冠状动脉损害情况及影响因素分析［J］.四川解剖学杂志,2019,27(2):80-82.
［10］陈婷婷,石坤,柳颐龄,等.川崎病患儿急性期心率变异性与降钙素原、超敏C反应蛋白的相关性［J］.中华实用儿科临床杂志,2017,32(21):1657-1660.
［11］李雪莲,朱绪亮,张俊,等.超敏C反应蛋白和血小板生成素对川崎病的临床意义［J］.中国现代药物应用,2017,11(19):74-75.
［12］梁春莉.川崎病患儿基质金属蛋白酶9、D二聚体、血沉、血小板与冠状动脉损伤的关系［J］.山西医科大学学报,2016,47(12):1112-1114.
［13］文元.114例川崎病患儿冠状动脉病变相关因素分析［J］.江苏医药,2015, 41(16):1960-1961.
［14］王丹,杨苏芬,陆卫民.川崎病患儿发生冠状动脉损害的相关危险因素分析［J］.中国医院统计,2018,25(2):126-128.
［15］何海玲,赖武超,温志红,等.小儿川崎病的临床特征及其并发冠状动脉病变的危险因素［J］.广西医学,2019,41(12):1502-1504.
［16］高文珺,范晓晨.丙球无反应性川崎病的诊断及治疗进展［J］.安徽医学,2017,38(7):951-954.